Halyard Health (NYSE:HYH) said late last month it tapped former Acelity prez & CEO Joseph Woody as its new chief executive officer, replacing a retiring Robert Abernathy. Woody will also assume a seat on the board of directors, with former CEO Abernathy continuing on as board chair, the Alpharetta, Ga.-based company said. “On behalf of the […]
IsoRay
IsoRay touts another ‘100%’ study
IsoRay (NYSE:ISR) today released data from a study of its Cesium-131 brachytherapy for treating patients with large brain metastases, touting a 100% freedom from local progression. Results from the study were published in the International Journal of Radiation Oncology, Biology, Physics, the Richland, Wash.-based company said. In the study, researchers assessed the impact of low-dose rate […]
Court OKs IsoRay’s $3.5m settlement
IsoRay (NYSE:ISR) said today that the US District Court for the Eastern District of Washington has approved a previously announced $3.5 million settlement related to a class action suit brought against it by shareholders last June. The Richland, Wash.-based company faced putative class-action lawsuits from investors, accusing the company of making false or misleading statements about a clinical trial of […]
Smith & Nephew pulls the trigger on planned CFO succession | Personnel Moves | January 20, 2017
Smith & Nephew (NYSE:SNN) said last week that CFO Julie Brown left the orthopedics & wound care company, after announcing her succession last July. Brown was named finance chief in November 2012 and assumed the role in February the following year. She is moving on to work as chief operating & financial officer for British luxury brand […]
IsoRay settles class action shareholders suit for $3.5m
IsoRay (NYSE:ISR) said it inked a $3.5 million settlement deal related to a class action suit brought against it by shareholders in June. The Richland, Wash.-based company is facing putative class-action lawsuits from investors, accusing the company of making false or misleading statements about a clinical trial of its Cesium 131 brachytherapy seeds designed to treat cancer in a press release […]
IsoRay touts brachytherapy brain cancer trial
IsoRay (NYSE:ISR) today released results from a prospective trial of intraoperative brachytherapy using its Cesium-131 brachytherapy seeds, touting that 95% of treated tumors showed no regrowth at the operative site. The study examined the use of the IsoRay’s seeds for treating recurrent aggressive meningiomas by applying seeds embedded in collagen tiles directly to brain tissue after […]
IsoRay spikes GliaSite radiation therapy device
IsoRay (NYSE:ISR) said yesterday that it’s spiking its GliaSite radiation therapy system for treating brain cancers, after achieving only modest sales since the FDA cleared the device in 2011. Richland, Wash.-based IsoRay said it’s cancelling its deals with Dr. Reddy’s Laboratories (NYSE:RDY), Hologic (NSDQ:HOLX) and Karlheinz Goehl-Medizintechnik Goehl concerning GliaSite. “The GliaSite product has resulted in only marginal […]
Icahn claims success, steps back from Hologic | Personnel Moves
Billionaire investor Carl Icahn said last Friday that he will begin to ramp down his involvement with Hologic (NSDQ:HOLX), claiming his intervention with the company to be a success. As part of the stepping away process, Icahn representatives Jonathan Christodoro and Samuel Merksamer stepped down from the board and will not be replaced, according to SEC […]
InspireMD CEO Milinazzo, CTO Bar to bow out | Personnel Moves
InspireMD (OTC:NSPR) said today that it’s looking for a replacement for CEO Alan Milinazzo as it looks to drill down on the largest markets for its CGuard and MGuard stents, which are designed to help prevent blood clots that can cause stroke. Milinazzo agreed to stay on until either a replacement is found or June 30, […]
HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board […]
Medtronic shuffles the deck | Personnel Moves
Medtronic (NYSE:MDT) today said it named Geoff Martha to be the new president of its restorative therapies division, replacing Christopher O’Connell, who left to take the CEO spot at Waters Corp. Martha is slated to be replaced in the chief integration officer role by Bill Burke, who joined Medtronic as part of its $50 billion acquisition […]
